Dr. Shaw is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Section of Infectious Diseases
Yale School of Medicine, 300 Cedar St., Box 208022
New Haven, CT 06520Phone+1 203-785-4140Fax+1 203-785-3864
Summary
- Dr. Albert Shaw is Professor of Medicine in the Section of Infectious Diseases at Yale School of Medicine. He received his MD from Harvard Medical School and PhD in Genetics from Harvard University and completed his residency in Internal Medicine and fellowship in Infectious Disease at Massachusetts General Hospital. He has a longstanding research interest in understanding mechanisms underlying age-associated alterations in the human immune response and in elucidating immunologic and gene expression signatures of vaccine response in older and frail older adults. Other research interests include circadian regulation of immune responses and immune dysfunction in patients with sickle cell disease.
Education & Training
- Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1994 - 1997
- Massachusetts General HospitalResidency, Internal Medicine, 1991 - 1994
- Harvard UniversityPhD, Genetics, 1985 - 1991
- Harvard Medical SchoolClass of 1991, MD
Certifications & Licensure
- CT State Medical License 2001 - 2025
- MA State Medical License 1998 - 2002
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Systems Investigation of Vaccine Responses in Aging and Frailty Start of enrollment: 2023 Nov 06
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsPlasma collagen neoepitopes are associated with multiorgan disease in the ACCESS and GRADS sarcoidosis cohorts.Jannie Marie Bülow Sand, Henrik Jessen, Diana Julie Leeming, Sheeline Yu, Chris J Lee
Thorax. 2024-11-14 - 1 citationsThe human CD47 checkpoint is targeted by an immunosuppressivesalivary factor to enhance arboviral skin infectivity.Alejandro Marin-Lopez, John D Huck, Allen T Esterly, Veronica Azcutia, Connor Rosen
Science Immunology. 2024-08-09 - 1 citationsFundamental and frontier research of immune responses to influenza vaccines in human aging: from cross-sectional and longitudinal studies to clinical trials and the ge...Sean X Leng, Albert C Shaw
Immunity & Ageing. 2023-11-29
Press Mentions
- What Can Be Done for Severe RSV Cases in Adults?December 20th, 2024
- GeroscienceSeptember 23rd, 2024
- Yale Doctor Says RSV Vaccine Approval ‘Really Exciting News’May 4th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: